Q1
Merck KGaA’s sales climb but key drugs fall
May 19, 2015Sales and Marketing Erbitux, Merck, Merck KGaA, Q1, Rebif
Merck KGaA encountered an uneven start to 2015, with robust sales in the first quarter offset by declines in key …
Generics continue to erode GSK sales
May 6, 2015Sales and Marketing GSK, HIV, Novartis, Q1, ViiV, Witty, hampton, respiratory
GlaxoSmithKline’s pharma sales continued to slide in the first quarter of 2015, but ViiV healthcare and the portfolios acquired from …
Pfizer posts second consecutive quarterly income decline
April 29, 2015Sales and Marketing 2015, Pfizer, Q1, first quarter
Pfizer made 4% less revenue in the first quarter of 2015 compared with the same period last year, the company’s …
Merck sales fall in Q1 despite new product lifts
April 29, 2015Sales and Marketing Merck, Q1, Remicade
Merck’s sales were down in the first quarter of 2015 thanks to its consumer care divestment and increasing competition for …
BMS lifted by new products
April 28, 2015Sales and Marketing BMS, NICE, Q1, eams, immuno-oncology and hepatitis C
New drugs have helped Bristol-Myers Squibb see a slight increase in sales for the first quarter of 2015. Total revenues …
Amgen files high earnings for Q1
April 22, 2015Sales and Marketing AMG 334, Amgen, Corlanor, Kyprolis, Prolia, Q1, Xgeva, brodalumab, myeloma, osteoporosis
Amgen has boosted its first quarter profit by 51% due to surging drug sales and ongoing cuts that paved the …
J&J strong pharma sales can’t offset Q1 losses
April 15, 2015Sales and Marketing J&J, JJ, Q1, Waldenström's macroglobulinemia, Waldenström’s Macroglobulinemia, Zytiga, abiraterone acetate, financials, ibrutinib, imbruvica
Johnson & Johnson’s pharma division achieved worldwide sales of $7.7 billion in the first quarter of this year – but …
Ranbaxy woes hit profits
May 13, 2014Manufacturing and Production, Sales and Marketing Q1, Ranbaxy, Sun Pharma, manufacturing, recall
Indian generics maker Ranbaxy Laboratories has slipped up in the first quarter of the year, with profit sliding to 0.3 …
GSK sees profit fall
May 1, 2014Sales and Marketing Advair, China, GSK, Novartis, Q1, Seretide, Witty
GlaxoSmithKline has seen revenue and profit plummet in the first quarter of 2014. The UK-based company saw turnover fall 13% …
Merck’s Q1 sales drop
April 30, 2014Sales and Marketing AstraZeneca, Merck, Pfizer, Q1, merger, quarter, sales
Merck & Co has released a mixed set of results for the first quarter of 2014, with drug revenue falling …
Novartis reports healthy profit
April 25, 2014Sales and Marketing Afinitor, Gleevec, Glivec, Novartis, Q1, lilly
Multiple sclerosis drug Gilenya and cancer treatment Afinitor were among the biggest sellers for Novartis, as the Swiss company’s net …
Profits slump at AstraZeneca
April 24, 2014Sales and Marketing AZD9291, AstraZeneca, BMS, Brilinta, Q1
AstraZeneca has continued its poor run of form, with operating profit in the first quarter of 2014 falling 40% on …
Sovaldi performs for Gilead
April 24, 2014Sales and Marketing Gilead, HCV, Q1, hepatitis C, sovaldi
Gilead Sciences’ once-daily, oral hepatitis C treatment Sovaldi has returned better than expected figures in the first quarter of the …
Sanofi’s performance dives
May 3, 2013Sales and Marketing Q1, Sanofi
Sanofi suffered a grim first three months of 2013, with sales dipping and profit plummeting as loss of exclusivity took …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
